Created at Source Raw Value Validated value
April 21, 2021, 2 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: They will receive control of the usual treatment for the disease according to the normal treatment regimen of the hospital including one 250 mg naproxen tablet every 12 hours (for 5 days), 500 mg azithromycin on the first day, and 250 mg on the second to fifth days, 40 mg famotidine every 12 hours for 5 days, and 25 mg prednisolone daily for 5 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: In addition to the routine treatment regimen, patients will receive a puff of PHR spray 160 (6 micrograms per puff) using a spacer,10 times a day during10 days. PHR160 spray made by Jabr Ibn Hayan Pharmaceutical Company was used in this trial.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2339, "treatment_name": "Phr-160", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]